Health Biogen and Bio-Thera Solutions Present Positive Phase 3 Data for Tocilizumab Biosimilar Candidate at the Annual European Congress of Rheumatology (EULAR 2022) June 3, 2022
Health New 12-Month Tofersen Data Presented at ENCALS Meeting Show Clinically Meaningful Benefit in People With SOD1-ALS June 3, 2022
Health SHAREHOLDER ALERT: ABBV SDIG UPST: The Law Offices of Vincent Wong Reminds Investors of Important Class Action Deadlines June 2, 2022
Health The Gross Law Firm Announces Class Actions on Behalf of Shareholders of ABBV, LILM and IIPR June 2, 2022
Health ROSEN, A LEADING, LONGSTANDING, AND TOP RANKED FIRM, Encourages AbbVie Inc. Investors with Losses to Secure Counsel Before Important June 6 Deadline in Securities Class Action – ABBV June 1, 2022